Business NewsPR NewsWire • Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen

Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen

Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen

STOCKHOLM, May 22, 2019 /PRNewswire/ -- This statement is made by the Board of Directors[1] of Nuevolution AB (publ) (the "Company" or "Nuevolution") pursuant to Rule II.19 of the Nasdaq Stockholm Takeover Rules (the "Takeover Rules"). Comment from Stig Løkke Pedersen, Chairman of the...

View More : https://www.prnewswire.com:443/news-releases/statement-by-the-board-of-directors-of-nuevolution-in-relation-to-the-publi...
Releted News by prnewswire
INVISIO Solution is Selected by USSOCOM for Next Generation Communications System
AR optical waveguide manufacturer Lingxi AR raised A+ round led by Sunny V Fund
Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss
Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen
Sasol Limited: Update on the Lake Charles Chemicals Project ('LCCP')
Daimler in transition: focus on sustainability, efficiency and mobility of the future
ITÁLIE: Mezinárodní veletrh fitness RiminiWellness se uskuteční od 30. května do 2. června 2019